PCOS Testing in Singapore: Where to Go, What It Costs, and the Panel That Gets Skipped
PCOS Testing in Singapore: Where to Go, What It Costs, and the Panel That Gets Skipped
If you've recently been diagnosed with PCOS — now renamed PMOS (Polyendocrine Metabolic Ovarian Syndrome) following the 2026 international consensus — you may be wondering whether you've had all the tests you need.
For many women, the first consultation understandably focuses on making the diagnosis and addressing the symptoms that brought them to the clinic. Depending on your symptoms and clinical situation, additional metabolic assessment may be considered as part of a broader evaluation.
This guide focuses on the practical questions many women ask in Singapore: where to go for testing, what the different healthcare pathways cost, and how metabolic assessment may fit into the overall evaluation of PMOS.
Why metabolic assessment matters
PMOS is increasingly recognized as a condition that affects more than the ovaries alone. Alongside reproductive symptoms, many women also experience changes in metabolism, although the pattern and severity vary considerably between individuals.
The Rotterdam criteria, which remain the current international diagnostic standard, require two of the following three features:
- irregular or absent ovulation
- clinical or biochemical evidence of excess androgens
- polycystic ovarian morphology on ultrasound.
These criteria allow doctors to diagnose PMOS accurately. However, the Rotterdam criteria are designed to establish the diagnosis. They do not, by themselves, provide a comprehensive assessment of metabolic health, which may require additional evaluation depending on a woman's symptoms, risk factors and clinical judgement.
This can be particularly relevant for women of Asian ancestry, who may develop insulin resistance and metabolic complications at lower BMI levels than European populations. Not every woman requires additional metabolic testing, but considering these factors helps ensure that assessment is tailored to the individual rather than based on reproductive symptoms alone.
Metabolic investigations: what may be considered
There is no single blood test that diagnoses PMOS.
The investigations recommended depend on the purpose of testing — whether to establish the diagnosis, assess metabolic health, or exclude other conditions that can present in a similar way. Routine investigations are guided by current international guidelines and tailored to your individual clinical presentation.
Depending on your symptoms, medical history and risk factors, your doctor may recommend additional metabolic or hormonal investigations. These may include:
- Androgen assessment, such as total testosterone and, where appropriate, free testosterone or calculated free androgen index (which requires SHBG).
- Assessment of glucose metabolism, with a 75 g oral glucose tolerance test preferred for women at increased risk of diabetes. Fasting glucose and/or HbA1c may also be appropriate in some situations.
- Additional metabolic assessment. Some clinicians may also consider fasting insulin or calculated indices such as HOMA-IR in selected patients as part of a broader metabolic evaluation, although these are not routine investigations recommended by current international guidelines.
Not every woman requires every investigation. The most appropriate tests depend on your symptoms, medical history, examination findings and your doctor's clinical judgement.
Your three routes
Subsidised GP clinic or Polyclinic
For women who wish to use the subsidised public healthcare pathway, a polyclinic or an eligible primary care doctor is usually the starting point. They can assess your symptoms, arrange appropriate initial investigations, and refer you to a specialist at a public hospital if further assessment is needed.
Consultations are subsidised for eligible patients, although fees vary depending on your subsidy status and the services provided — for citizens, a subsidised polyclinic consultation is typically on the order of S$15–20.
Subsidised specialist (KKH, NUH or SGH)
Patients referred to the public healthcare system may be seen at specialist outpatient clinics in hospitals such as KK Women's and Children's Hospital (KKH), National University Hospital (NUH) and Singapore General Hospital (SGH).
This pathway generally offers lower consultation costs through government subsidies for eligible patients — citizens receive up to a 70% means-tested subsidy, so a first specialist consult typically lands around S$30–60. Waiting times for non-urgent appointments may be longer than in the private sector: in 2024 the median wait for a subsidised referral to a public specialist clinic was about a month, and a non-urgent condition like PMOS can sit at the longer end.
Private specialist
Women may also choose to see a private gynecologist or endocrinologist directly, without first attending a polyclinic or GP clinic.
Private care generally offers earlier appointments and greater continuity with the same specialist, with consultations, investigations, and imaging paid for privately — a first specialist consult runs roughly S$120–350 (gynecologist) to S$150–350 (endocrinologist), a hormone panel around S$150–350 depending on the number of markers, and a pelvic ultrasound roughly S$150–350.
The investigations available are generally similar in both the public and private sectors. The main differences are cost, waiting time, and continuity of care.
Endocrinologist or gynecologist?
Both specialists diagnose and manage PMOS, but they often approach the condition from different perspectives.
A gynecologist focuses primarily on reproductive health, including menstrual irregularities, ovulation, fertility and management of the uterine lining.
An endocrinologist focuses on hormones and metabolism, including insulin resistance, diabetes risk, thyroid disease and other endocrine conditions that may coexist with PMOS.
The most appropriate specialist depends on your main concerns, and many women see both over the course of their care.
What subsidies actually cover
Singapore's healthcare subsidies help reduce the cost of consultations and specialist care, although the level of subsidy depends on the patient's eligibility, diagnosis, and healthcare setting.
CHAS subsidies primarily support GP consultations, chronic disease management, and selected dental services. While investigations such as blood tests may be subsidised when they are part of an eligible consultation or chronic disease management, routine diagnostic blood tests may still incur additional out-of-pocket charges.
Likewise, MediSave generally cannot be used for routine outpatient diagnostic investigations unless they are covered under specific approved schemes, such as the Chronic Disease Management Programme (CDMP), certain preventive screening programmes, or other eligible outpatient treatments.
If you're unsure what is covered, it's worth asking your clinic before your appointment so you have a clear understanding of any potential out-of-pocket costs.
Preparing for your appointment
Short consultations are often more productive when you arrive with a clear understanding of your symptoms, concerns and goals.
If you're wondering whether additional metabolic assessment might be relevant, consider discussing this with your doctor based on your individual circumstances, particularly if you have irregular periods, a family history of diabetes, difficulty managing weight, or other features suggestive of metabolic dysfunction.
It's also worth remembering that PMOS can occur in women of all body sizes. A normal BMI does not exclude the condition, and women of Asian ancestry may develop metabolic complications at lower BMI levels than those traditionally used in Western populations.
Where to start
If you're unsure whether your symptoms are consistent with PMOS, our free 5-minute assessment provides an overview of the metabolic, hormonal and reproductive patterns that may be contributing to your symptoms. The results can help you better understand your condition and support discussions with your healthcare professional.
Once your assessment is complete, lifestyle measures — including nutrition, physical activity and sleep — remain an important part of long-term PMOS management alongside appropriate medical care. For the Singapore version of eating well, see our guide to eating for PMOS at the hawker center.
Citations
- Teede HJ, et al. Renaming polycystic ovary syndrome. The Lancet, 2026 May 12. (Consensus statement.)
- Sex hormone-binding globulin and metabolic phenotype in Asian women with PCOS. NUS cohort, 2024. (Observational cohort.)
- International evidence-based guideline for the assessment and management of polycystic ovary syndrome, 2023. (Clinical guideline — Rotterdam criteria.)
- Barriers and enablers to implementing lifestyle management for women with PCOS in Singapore. (Qualitative study, PMC4910192.)
- Ministry of Health Singapore — Subsidies for Specialist Outpatient Care at Public Healthcare Institutions (Singapore citizens: up to 70% means-tested subsidy).
- Ministry of Health Singapore — Wait time for primary-care referral to public hospital Specialist Outpatient Clinics (median ~35 days for subsidised patients, 2024).
- SingHealth Polyclinics — Charges and Payment (polyclinic consultation fees). Private consult, panel, and ultrasound ranges are from published clinic fee schedules and vary by provider.